Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedMAb1-Ex phase 1 bNAb safety and pharmacokinetics study in adults and HIV-exposed uninfected neonates/infants
PACTR202603555334830Phase 1Not yet recruiting
- Sponsor
- South African Medical Research Council
- Start
- Jan 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of VRC07-523LS in human immunodeficiency virus infection (HIV) (2 arms), sponsored by South African Medical Research Council. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
VRC07-523LS
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202603555334830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603555334830.